You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
20 April 2026 - Biopharmaceutical company GSK plc (LSE: GSK) (NYSE: GSK) declared on Monday that it has received approval from China's National Medical Products Administration for Blenrep (belantamab mafodotin) in combination with bortezomib and...
20 April 2026 - French healthcare company Sanofi S.A. (Euronext Paris:SAN) (Nasdaq:SNY) announced on Saturday that its protein-based COVID-19 vaccine, Nuvaxovid (NVX-CoV2705), showed statistically significant lower systemic reactogenicity compared to...
20 April 2026 - Biopharmaceutical company AstraZeneca PLC (LSE: AZN) (STO: AZN) (NYSE: AZN) on Monday reported positive high-level results from the Phase III MIRANDA trial, demonstrating that its IL-33-targeting biologic, tozorakimab, achieved a stat...
20 April 2026 - Clinical-stage biopharmaceutical company Accent Therapeutics on Friday presented preclinical data supporting its potentially best-in-class KIF18A inhibitor, ATX-295, at the American Association for Cancer Research (AACR) Annual Meetin...
20 April 2026 - Life science technology company 10x Genomics Inc (Nasdaq:TXG) on Saturday introduced Atera, an in situ spatial biology platform designed to deliver whole-transcriptome spatial analysis with single-cell sensitivity at unprecedented sca...